 PURPOSE: Although the pharmacokinetics of each of these asparaginase preparations: intravenous PEG-asparaginase IV-PEG and intramuscular native E coli L-asparaginase IM-EC have been well characterized, their relative efficacy and toxicity have not been studied extensively. 